Showing results (1631-1640 of 1,677) with videos related to

Sort By:
Pageof 168
Hepatology International|December 1, 2021
Immunotherapy of HBV-related advanced hepatocellular carcinoma with short-term HBV-specific TCR expressed T cells: results of dose escalation, phase I trialFanping Meng, Jinfang Zhao, Anthony Tanoto Tan, et al.
Oncogene|July 12, 2018
CPT1A-mediated fatty acid oxidation promotes colorectal cancer cell metastasis by inhibiting anoikisYing-Nan Wang, Zhao-Lei Zeng, Jiahuan Lu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2022
Long-Term Follow-Up of Combination of B-Cell Maturation Antigen and CD19 Chimeric Antigen Receptor T Cells in Multiple MyelomaYing Wang, Jiang Cao, Weiying Gu, et al.
Nutrients|September 9, 2023
Dietary Diversity Changes and Cognitive Frailty in Chinese Older Adults: A Prospective Community-Based Cohort StudyWen-Fang Zhong, Wei-Qi Song, Xiao-Meng Wang, et al.
Experimental Hematology & Oncology|June 17, 2026
Autophagy-promoted immunogenic cell death elicited by tyrosine kinase inhibitor orchestrates a synergistic immunotherapeutic microenvironment in hepatocellular carcinomaShan-Ru Feng, En-Fu Dong, Zheng Gao, et al.
Cell|November 23, 2024
Atlas of the plasma proteome in health and disease in 53,026 adultsYue-Ting Deng, Jia You, Yu He, et al.
Cell Metabolism|July 2, 2020
Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 PathogenesisJin-Wen Song, Sin Man Lam, Xing Fan, et al.
Nature Cancer|August 21, 2025
Colorectal cancer cells hijack a brain-gut polysynaptic circuit from the lateral septum to enteric neurons to sustain tumor growthYing Li, Hao Yu, Zi-Ming Li, et al.
Signal Transduction and Targeted Therapy|March 17, 2023
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 studyGuo-Ming Shi, Xiao-Yong Huang, Dong Wu, et al.
Frontiers in Immunology|September 16, 2021
CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic CholangiocarcinomaXiao-Jun Guo, Jia-Cheng Lu, Hai-Ying Zeng, et al.
Pageof 168